Solid Biosciences Inc. — Director's Dealing 2019

Jul 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2019-07-25

Reporting Person: Shah Rajeev M. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-25	Common Stock	A	1881720	$4.65	Acquired	4571164	Indirect

Footnotes

F1: Includes 1,593,629 shares of Common Stock that are held by RA Capital Healthcare Fund, L.P. (the "Fund") and 288,091 shares of Common Stock that are held in an account owned by a separately managed account (the "Account").

F2: Following the reported transaction, the Fund held 3,771,600 shares and the Account held 799,564 shares.

F3: RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Account. Peter Kolchinsky is the sole manager of the Adviser, and Mr. Shah is a member of the Adviser. Mr. Shah has no pecuniary interest in the reported securities held in the Account and therefore disclaims beneficial ownership of those securities. Mr. Shah disclaims beneficial ownership of the reported securities held by the Fund except to the extent of his pecuniary interest therein.